InvestorsHub Logo
Followers 138
Posts 23699
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Friday, 10/18/2019 10:25:53 AM

Friday, October 18, 2019 10:25:53 AM

Post# of 469773
The company is well positioned to achieve key clinical readouts
Phase 2b/3 clinical trial in Alzheimer’s disease – ongoing
Phase 2 clinical trial in Parkinson’s disease dementia (PDD) – ongoing
Initiate Phase 2 clinical trial in Rett syndrome (RTT)
Oral presentation at AAIC July 17, 2019: Gut microbiota data Phase 2a (AD) Topline data Phase 2 Rett syndrome (RTT) Part A
Topline data Phase 2 Rett syndrome (RTT) Part B
Topline data Phase 2 Parkinson’s disease dementia (PDD)
Data publications in 2019
New indications and licensing opportunities
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News